Business Update
Invitrogen launches new E-Gel product, awarded $16M in patent suit win
Published in Lab Law Weekly, January 26th, 2007
According to the company, these gels provide a fast and convenient way to obtain improved cloning efficiency without exposing the user to harmful UV transillumination.
Users of these new products can avoid gel slicing and UV exposure, leading to a safer and more efficient DNA recovery method. The DNA is stained with nontoxic, nonmutagenic SYBR Safe stain, which is visualized with the Safe Imager device to deliver DNA free of strand breaks and mutations, resulting, the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2007-01-26)
More Articles from Lab Law Weekly
- Alzheimer Disease
Alzheimer's Association reports patients can retain independence longer with technology - Business & Finance
IRIDEX now current on its U.S. Securities & Exchange Commission filings - Business Update
Barr confirms generic Thalomid capsule application to the U.S. FDA - Business Update
Coalition America, Healthx and Bloodhound Technologies plan joint client conference - Business Update
Southern Oncology Association of Practices extends oncology services agreements with OTN, Onmark - Business Update
Urigen N.A. hires law firm Sichenzia Ross Friedman Ference to oversee Valentis merger - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
